Arvinas, Inc.Arvinas, Inc.Arvinas, Inc.

Arvinas, Inc.

No trades
See on Supercharts
Market capitalization
‪2.34 B‬USD
−6.50USD
‪−367.30 M‬USD
‪78.50 M‬USD
‪58.38 M‬
Beta (1Y)
2.63

About Arvinas, Inc.

CEO
John G. Houston
Headquarters
New Haven
Employees (FY)
445
Founded
2013
ISIN
US04335A1051
FIGI
BBG00LW7YK82
Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ARVN is 34.29 USD — it has increased by 2.51% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arvinas, Inc. stocks are traded under the ticker ARVN.
Arvinas, Inc. is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
ARVN stock is 5.67% volatile and has beta coefficient of 2.63. Check out the list of the most volatile stocks — is Arvinas, Inc. there?
One year price forecast for Arvinas, Inc. has a max estimate of 110.00 USD and a min estimate of 49.00 USD.
ARVN earnings for the last quarter are −1.18 USD per share, whereas the estimation was −1.58 USD resulting in a 25.45% surprise. The estimated earnings for the next quarter are −1.19 USD per share. See more details about Arvinas, Inc. earnings.
Arvinas, Inc. revenue for the last quarter amounts to ‪34.60 M‬ USD despite the estimated figure of ‪39.45 M‬ USD. In the next quarter revenue is expected to reach ‪48.33 M‬ USD.
Yes, you can track Arvinas, Inc. financials in yearly and quarterly reports right on TradingView.
ARVN stock has fallen by 12.35% compared to the previous week, the month change is a 16.83% fall, over the last year Arvinas, Inc. has showed a 27.38% increase.
ARVN net income for the last quarter is ‪−154.80 M‬ USD, while the quarter before that showed ‪−64.00 M‬ USD of net income which accounts for −141.88% change. Track more Arvinas, Inc. financial stats to get the full picture.
Today Arvinas, Inc. has the market capitalization of ‪2.33 B‬, it has decreased by 3.56% over the last week.
No, ARVN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ARVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arvinas, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ARVN reached its all-time high on Jul 29, 2021 with the price of 108.47 USD, and its all-time low was 10.19 USD and was reached on Dec 21, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 445.00 employees. See our rating of the largest employees — is Arvinas, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Arvinas, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Arvinas, Inc. stock shows the sell signal. See more of Arvinas, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Arvinas, Inc. future price: according to them, ARVN price has a max estimate of 110.00 USD and a min estimate of 49.00 USD. Read a more detailed Arvinas, Inc. forecast: see what analysts think of Arvinas, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Arvinas, Inc. EBITDA is ‪−394.80 M‬ USD, and current EBITDA margin is −502.93%. See more stats in Arvinas, Inc. financial statements.